Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
26 Gennaio 2022 - 11:01PM
Edgar (US Regulatory)
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of January 2022
Commission File Number: 001-38562
NEW
FRONTIER HEALTH CORPORATION
(Translation of Registrant’s Name into English)
10 Jiuxianqiao Road,
Hengtong Business Park
B7 Building, 1/F
Chaoyang District, 100015
Beijing,
China
(Address of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F
x Form 40-F ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes ¨
No ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes ¨
No ¨
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
New
Frontier Health Corporation
|
|
|
|
|
By:
|
/s/
Carl Wu
|
|
|
Name:
|
Carl Wu
|
|
|
Title:
|
Director
|
Date: January 26, 2022
Grafico Azioni New Frontier Health (NYSE:NFH)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni New Frontier Health (NYSE:NFH)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a New Frontier Health Corporation (Borsa di New York (NYSE)): 0 articoli recenti
Più New Frontier Health Corp Articoli Notizie